the mean uterine wall thickness was 8.05 (SD 2.29) mm and 8.05 (SD 2.24); the mean interostial line was 37.99 (SD 8.33) and 38.00 (SD 8.39); the mean internal midline indentation was 17.06 (SD 9.76) mm and 17.10 (SD 9.80); and the mean external indentation was 7.20 (SD 5.37) and 7.07 (SD 5.21).The Intra-class correlation coefficients were 0.99 for the interostial line, uterine wall thickness, and the external indentation and 1 for internal midline indentation (p<0.05). Conclusions: Three-dimensional ultrasound uterine measurements described in the ESHRE-ESGE consensus and the Thessaloniki ESHRE-ESGE consensus showed a good level of inter-observer reproducibility.
Objectives: Uterine Peristalsis (UP) plays a fundamental role in fertilisation. UP outside pregnancy can be evaluated by visual inspection of transvaginal ultrasound (TVUS); however, this procedure is subjective and unsuitable for UP quantification. High-order texture US image analysis has proven effective in the investigation of muscle structure. In particular, Gray Level Non-Uniformity (GLNU) computed on a Region Of Interest (ROI) defines texture absolute coarseness. In this pilot study, we propose a novel approach for the quantification of texture dynamic changes in uterine contracting areas during different phases of the menstrual cycle. Methods: Three healthy patients underwent 4 minutes-TVUS examination during active (periovulation) and inactive (Ovulation + 7 days) phases. We compute the GLNU on two ROIs (Dorsal and Ventral), placed in correspondence of the adopted visual inspection line (figure 1). Root-mean-square (RMS) and signal time-delays were computed to quantify UP amplitude and propagation speed, respectively. Results: For the three patients, the average RMS of GLNU signals were 13.10 ± 12.83 a.u. for and 4.90 ± 3.05 a.u. for the active and inactive phases, respectively. Average UP propagation speeds were computed in both directions (DV = Dorsal-Ventral, VD = Ventral-Dorsal) in active (DV: 1.48 ± 1.13 mm/s, VD: 0.82 ± 0.10 mm/s) and inactive phase (DV: 1.00 ± 0.35 mm/s, VD: 0.81 ± 0.13 mm/s). Good qualitative agreement between time-delay onset and visual inspection observations was observed in active phase. Conclusions: High-order texture analysis can be used to assess pattern changes in adjacent regions over time and along a direction. GLNU amplitude changes and propagation speed are higher in active phase, confirming that UP characteristics change throughout the menstrual cycle.
Supporting information can be found in the online version of this abstract Objectives: To appraise the current evidence comparing double and single intrauterine insemination (IUI) on the reproductive outcomes in subfertile couples. Methods: Only RCTs were included in this review (PROSPERO CRD42016043877); the searches were run in 4 databases. Data was subgrouped by the quality of the semen. Sensitivity analysis included the restriction of inclusion to only studies at low risk of bias and the use of fixed-effect model. The evaluation of the risk of bias within each study was structured using the Cochrane risk of bias and the overall quality of the body of evidence was assessed through the GRADE criteria.
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Results: 15 studies were included encompassing 3,795 women; 1,246 in the subgroup 'mild male infertility' and 1,188 in 'normal semen quality'. Clinical pregnancy was reported by all studies, and there is no evidence of a difference between single and double IUI (figure 1). We could not identify a particular subgroup that could benefit from the intervention. Evidence for live birth, ectopic pregnancy, and miscarriage was too imprecise because they were reported by too few studies. Conclusions: Currently, there is no evidence to support the use of double IUI in clinical practice. It requires a second appointment and insemination, thus making the treatment more complex and expensive, without a clear evidence of a benefit. Nevertheless, evidence is still of low quality and our confidence in the effect estimate is limited: the true effect may be substantially different from the hereby demonstrated.
Supporting information can be found in the online version of this abstract Mar-2017 . Any type of HPV infection in the woman assessed through PCR, subfertility factors and IVF indications and protocols were considered. Our outcomes were live birth/ongoing pregnancy, clinical pregnancy and miscarriage. We assessed the relative risk (RR), using a random-effects model; heterogeneity was assessed by I 2 statistics. The quality of the evidence was evaluated using the recommendations from GRADE working group. Results: Data from eight studies evaluating 208 women with HPV infection and 965 women without HPV infection were included in the analyses. The pooled results showed no significant difference in live birth/ongoing pregnancy (RR=1.16, 95%CI=0.88-1.53, I 2 =0%, 6 studies, 983 women), clinical pregnancy (RR=1.06, 95%CI=0.74-1.54, I 2 =61%, 8 studies, 1173 women), and miscarriage rates (RR=1.58, 95%CI=0.93-2.69, I 2 =8%, 6 studies, 290 clinical pregnancies). The overall quality of the evidence was very low, downgraded two levels because of serious limitations of included studies (observational studies) and imprecision. Conclusions: The available evidence is still insufficient to conclude about the effect of the HPV infection of the woman have on the most important reproductive outcomes following IVF; however, it suggests that the effect (negative or positive) is not very large for live birth/ongoing pregnancy and clinical pregnancy rates. 
